Alberta's Clinical Trials Alberta (CTA) initiative, launched in 2021, highlights the province's robust health research infrastructure, attracting global clinical trials. CTA, a collaboration of government, academic, and healthcare entities, promotes Alberta's unique assets, including a centralized clinical trial management system and a diverse patient population, to boost industry R&D, create jobs, and diversify the economy. Alberta Innovates' investments in provincial platform systems and the REB Exchange have enhanced research efficiency, while events like Alberta BioPartners facilitate global connections. Clinical trials not only improve healthcare but also generate substantial economic benefits, contributing to Alberta's GDP growth.